Rifamycin S

CAS : 13553-79-2

Ref. 3D-FR151216

Informations sur le produit

• Nom: Rifamycin S
• Synonymes: 1,4-Dideoxy-1,4-dioxo-rifamycin, (14E,24E)-5,17,19-trihydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,6,9,11-tetraoxo-1,2,6,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,17,19-trihydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,6,9,11-tetraoxo-1,2,6,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate, 1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin, 1,4-Dideoxy-1,4-dihydro-1,4-dioxorifamycin, 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv., 5,17,19-Trihydroxy-23-Methoxy-2,4,12,16,18,20,22-Heptamethyl-1,6,9,11-Tetraoxo-1,2,6,9-Tetrahydro-2,7-(Epoxypentadeca[1,11,13]Trienoimino)Naphtho[2,1-B]Furan-21-Yl Acetate, Brn 0604802, Nci 144-130, Nsc 144130, Rifamycin, 1,4-dideoxy-1,4-dihydro-1,4-dioxo-, Rifomycin S, Unii-Pi53N820Jv

Description

Rifamycin S is a rifamycin that is used as a model system to study the activity of other drugs. It is also used to treat infectious diseases, such as bowel disease, by inhibiting bacterial growth. Rifamycin S has been shown to have drug interactions with other drugs and can cause acute toxicities in the form of multivariate logistic regression. It has also been shown to inhibit the enzymatic inactivation of a number of antibiotics, such as methicillin and penicillin, which may be due to its ability to bind DNA templates. Rifamycin S has also been shown to have antibacterial effects against some bacteria, including Mycobacterium tuberculosis and Mycobacterium avium.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 695.75 g/mol
• Formule: C₃₇H₄₅NO₁₂
• Degré de pureté: Min. 96 Area-%
• Couleur/Forme: Powder